JP6991593B2 - Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 - Google Patents
Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 Download PDFInfo
- Publication number
- JP6991593B2 JP6991593B2 JP2019545223A JP2019545223A JP6991593B2 JP 6991593 B2 JP6991593 B2 JP 6991593B2 JP 2019545223 A JP2019545223 A JP 2019545223A JP 2019545223 A JP2019545223 A JP 2019545223A JP 6991593 B2 JP6991593 B2 JP 6991593B2
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- terminal
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0149090 | 2016-11-09 | ||
| KR20160149090 | 2016-11-09 | ||
| PCT/KR2017/012651 WO2018088813A2 (ko) | 2016-11-09 | 2017-11-09 | Nkx3.2 단편 및 이를 유효성분으로 포함하는 약학 조성물 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020183392A Division JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535310A JP2019535310A (ja) | 2019-12-12 |
| JP2019535310A5 JP2019535310A5 (enExample) | 2020-12-17 |
| JP6991593B2 true JP6991593B2 (ja) | 2022-01-12 |
Family
ID=62110655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545223A Active JP6991593B2 (ja) | 2016-11-09 | 2017-11-09 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
| JP2020183392A Active JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020183392A Active JP7055455B2 (ja) | 2016-11-09 | 2020-11-02 | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11235025B2 (enExample) |
| EP (2) | EP3539978B1 (enExample) |
| JP (2) | JP6991593B2 (enExample) |
| KR (4) | KR102049987B1 (enExample) |
| CN (2) | CN110036023B (enExample) |
| AU (2) | AU2017358282C1 (enExample) |
| CA (1) | CA3042186C (enExample) |
| ES (2) | ES2987020T3 (enExample) |
| WO (1) | WO2018088813A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3060947B1 (fr) * | 2016-12-28 | 2025-12-26 | Ynsect | Procede de traitement d'insectes comprenant la separation des cuticules de la partie molle des insectes puis la separation de la partie molle en trois fractions |
| CA3112915A1 (en) * | 2018-10-19 | 2020-04-23 | Icm Co., Ltd. | Pharmaceutical composition for treating retinal diseases, comprising nkx3.2 and fragment thereof as active ingredients |
| KR102336515B1 (ko) * | 2018-10-25 | 2021-12-07 | 애니젠 주식회사 | 부포린 유도체 및 이의 용도 |
| CN112409454B (zh) * | 2020-11-04 | 2022-07-05 | 青岛农业大学 | 一种法氏囊七肽及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| BR112012004777A2 (pt) * | 2009-09-03 | 2019-09-24 | Genentech Inc | métodos para tratar diagnósticar e monitorar artrite reumatoide |
| WO2011093647A2 (en) * | 2010-01-26 | 2011-08-04 | Industry-Academic Cooperation Foundation, Yonsei University | Genes implicated in osteoarthritis and use thereof |
| KR101150900B1 (ko) * | 2010-01-26 | 2012-05-30 | 연세대학교 산학협력단 | 퇴행성 관절염 치료 조성물 |
| KR101150990B1 (ko) | 2010-06-19 | 2012-06-13 | 김유정 | 슬롯리스 고정자를 갖는 브러시리스 직류 모터 |
| WO2012097057A2 (en) * | 2011-01-11 | 2012-07-19 | Tufts University | Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells |
| UY35368A (es) * | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| CA2915296A1 (en) * | 2013-06-11 | 2015-02-26 | Portage Pharmaceuticals Ltd. | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides |
| KR102044530B1 (ko) | 2017-04-21 | 2019-11-14 | 아이씨엠 주식회사 | Nkx3.2 및 이의 단편을 유효성분으로 포함하는 망막질환 치료용 약학적 조성물 |
-
2017
- 2017-11-09 EP EP17868981.6A patent/EP3539978B1/en active Active
- 2017-11-09 WO PCT/KR2017/012651 patent/WO2018088813A2/ko not_active Ceased
- 2017-11-09 EP EP21154441.6A patent/EP3835311B1/en active Active
- 2017-11-09 CN CN201780069569.5A patent/CN110036023B/zh active Active
- 2017-11-09 CA CA3042186A patent/CA3042186C/en active Active
- 2017-11-09 ES ES21154441T patent/ES2987020T3/es active Active
- 2017-11-09 KR KR1020170148493A patent/KR102049987B1/ko active Active
- 2017-11-09 JP JP2019545223A patent/JP6991593B2/ja active Active
- 2017-11-09 ES ES17868981T patent/ES3009014T3/es active Active
- 2017-11-09 CN CN202211029784.1A patent/CN115925865A/zh active Pending
- 2017-11-09 AU AU2017358282A patent/AU2017358282C1/en active Active
- 2017-11-09 KR KR1020170148509A patent/KR102049978B1/ko active Active
- 2017-11-09 US US16/348,540 patent/US11235025B2/en active Active
-
2019
- 2019-11-05 KR KR1020190140236A patent/KR102340761B1/ko active Active
-
2020
- 2020-02-28 US US16/805,370 patent/US11154590B2/en active Active
- 2020-07-24 AU AU2020207879A patent/AU2020207879B2/en active Active
- 2020-11-02 JP JP2020183392A patent/JP7055455B2/ja active Active
- 2020-11-02 KR KR1020200144613A patent/KR102342171B1/ko active Active
Non-Patent Citations (1)
| Title |
|---|
| Database GenPept[online], Accession No.NP_001180, 2015-12-24 uploaded, [retrieved on 2021-10-22], <https://www.ncbi.nlm.nih.gov/protein/4502365?sat=46&satkey=37927784>, Definition:homeobox protein Nkx-3.2 [Homo sapiens] |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7055455B2 (ja) | Ｎｋｘ３．２断片及び活性成分としてＮｋｘ３．２断片を含む医薬組成物 | |
| US7175844B2 (en) | Methods of modulating fibrosis | |
| JP2014520123A (ja) | Ｃｌｅｃ−２を使用して代謝性障害を治療または改善させる方法 | |
| JP2005504010A (ja) | 成長ホルモンおよびｆｏｘｍ１ｂを用いた肝臓疾患および肝臓損傷の処置方法 | |
| US20200048318A1 (en) | Myomerger polypeptides, nucleic acid molecules, cells, and related methods | |
| US11560412B2 (en) | Compositions comprising GRIM-19 therapeutics and methods of use | |
| US7507712B2 (en) | NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer | |
| JP2005508875A (ja) | 転座因子として使用するためのペプチド | |
| WO2021062012A1 (en) | Use of klk10 and engineered derivatizations thereof | |
| US7727526B2 (en) | Use of PTHrP antagonists for treating renal cell carcinoma | |
| JP2004517620A (ja) | ダイダロス（Ｄａｅｄａｌｏｓ）による神経発生の調節方法 | |
| US20050201995A1 (en) | Methods and compositions related to neuronal differentiation | |
| 이상환 | Effects of AAV-Mediated Delivery of HGF Gene on the Muscular and Nerve Systems in the Nerve Crush and SOD1-G93A Transgenic Mouse Models | |
| CN117813321A (zh) | 视网膜病症 | |
| WO2015110707A1 (en) | Methods and uses related to adamts3 | |
| AU2002342728A1 (en) | Methods for treating liver disease and liver damage with growth hormone and FoxM1B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201102 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201102 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211102 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211201 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6991593 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |